Logo image of RVTY

REVVITY INC (RVTY) Stock Fundamental Analysis

NYSE:RVTY - New York Stock Exchange, Inc. - US7140461093 - Common Stock - Currency: USD

93.58  -0.72 (-0.76%)

After market: 93.58 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to RVTY. RVTY was compared to 56 industry peers in the Life Sciences Tools & Services industry. While RVTY belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. RVTY has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year RVTY was profitable.
In the past year RVTY had a positive cash flow from operations.
Each year in the past 5 years RVTY has been profitable.
In the past 5 years RVTY always reported a positive cash flow from operatings.
RVTY Yearly Net Income VS EBIT VS OCF VS FCFRVTY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

1.2 Ratios

Looking at the Return On Assets, with a value of 2.32%, RVTY is in the better half of the industry, outperforming 75.00% of the companies in the same industry.
RVTY has a better Return On Equity (3.75%) than 73.21% of its industry peers.
Looking at the Return On Invested Capital, with a value of 2.71%, RVTY is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for RVTY is significantly below the industry average of 12.97%.
Industry RankSector Rank
ROA 2.32%
ROE 3.75%
ROIC 2.71%
ROA(3y)3.77%
ROA(5y)5.35%
ROE(3y)6.68%
ROE(5y)10.55%
ROIC(3y)3.45%
ROIC(5y)6.13%
RVTY Yearly ROA, ROE, ROICRVTY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

RVTY has a Profit Margin of 10.35%. This is amongst the best in the industry. RVTY outperforms 80.36% of its industry peers.
RVTY's Profit Margin has improved in the last couple of years.
With a decent Operating Margin value of 14.50%, RVTY is doing good in the industry, outperforming 75.00% of the companies in the same industry.
In the last couple of years the Operating Margin of RVTY has grown nicely.
With a decent Gross Margin value of 56.25%, RVTY is doing good in the industry, outperforming 69.64% of the companies in the same industry.
RVTY's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 14.5%
PM (TTM) 10.35%
GM 56.25%
OM growth 3Y-24.12%
OM growth 5Y2.06%
PM growth 3Y-26.42%
PM growth 5Y4.45%
GM growth 3Y-4.25%
GM growth 5Y2.89%
RVTY Yearly Profit, Operating, Gross MarginsRVTY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

6

2. Health

2.1 Basic Checks

RVTY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for RVTY has been reduced compared to 1 year ago.
RVTY has more shares outstanding than it did 5 years ago.
The debt/assets ratio for RVTY has been reduced compared to a year ago.
RVTY Yearly Shares OutstandingRVTY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
RVTY Yearly Total Debt VS Total AssetsRVTY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 2.60 indicates that RVTY is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of RVTY (2.60) is better than 62.50% of its industry peers.
RVTY has a debt to FCF ratio of 6.05. This is a slightly negative value and a sign of low solvency as RVTY would need 6.05 years to pay back of all of its debts.
The Debt to FCF ratio of RVTY (6.05) is better than 60.71% of its industry peers.
A Debt/Equity ratio of 0.41 indicates that RVTY is not too dependend on debt financing.
RVTY's Debt to Equity ratio of 0.41 is in line compared to the rest of the industry. RVTY outperforms 46.43% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 6.05
Altman-Z 2.6
ROIC/WACC0.28
WACC9.64%
RVTY Yearly LT Debt VS Equity VS FCFRVTY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

RVTY has a Current Ratio of 3.58. This indicates that RVTY is financially healthy and has no problem in meeting its short term obligations.
RVTY's Current ratio of 3.58 is in line compared to the rest of the industry. RVTY outperforms 55.36% of its industry peers.
RVTY has a Quick Ratio of 2.99. This indicates that RVTY is financially healthy and has no problem in meeting its short term obligations.
RVTY's Quick ratio of 2.99 is in line compared to the rest of the industry. RVTY outperforms 55.36% of its industry peers.
Industry RankSector Rank
Current Ratio 3.58
Quick Ratio 2.99
RVTY Yearly Current Assets VS Current LiabilitesRVTY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

RVTY shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.71%.
RVTY shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 3.63% yearly.
Looking at the last year, RVTY shows a small growth in Revenue. The Revenue has grown by 1.62% in the last year.
The Revenue has been decreasing by -0.91% on average over the past years.
EPS 1Y (TTM)6.71%
EPS 3Y-24.58%
EPS 5Y3.63%
EPS Q2Q%3.06%
Revenue 1Y (TTM)1.62%
Revenue growth 3Y-10.38%
Revenue growth 5Y-0.91%
Sales Q2Q%2.25%

3.2 Future

RVTY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.62% yearly.
Based on estimates for the next years, RVTY will show a small growth in Revenue. The Revenue will grow by 5.39% on average per year.
EPS Next Y2.6%
EPS Next 2Y7.31%
EPS Next 3Y9.13%
EPS Next 5Y13.62%
Revenue Next Year3.45%
Revenue Next 2Y4.71%
Revenue Next 3Y5.29%
Revenue Next 5Y5.39%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
RVTY Yearly Revenue VS EstimatesRVTY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B 5B
RVTY Yearly EPS VS EstimatesRVTY Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.98, RVTY is valued on the expensive side.
RVTY's Price/Earnings ratio is rather cheap when compared to the industry. RVTY is cheaper than 80.36% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 26.60. RVTY is valued slightly cheaper when compared to this.
RVTY is valuated correctly with a Price/Forward Earnings ratio of 16.59.
Based on the Price/Forward Earnings ratio, RVTY is valued cheaply inside the industry as 82.14% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.43. RVTY is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.98
Fwd PE 16.59
RVTY Price Earnings VS Forward Price EarningsRVTY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, RVTY is valued cheaply inside the industry as 83.93% of the companies are valued more expensively.
RVTY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. RVTY is cheaper than 80.36% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.45
EV/EBITDA 16.31
RVTY Per share dataRVTY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
RVTY has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)7.3
PEG (5Y)5.23
EPS Next 2Y7.31%
EPS Next 3Y9.13%

6

5. Dividend

5.1 Amount

With a yearly dividend of 0.31%, RVTY is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 0.53, RVTY pays a better dividend. On top of this RVTY pays more dividend than 85.71% of the companies listed in the same industry.
With a Dividend Yield of 0.31, RVTY pays less dividend than the S&P500 average, which is at 2.36.
Industry RankSector Rank
Dividend Yield 0.31%

5.2 History

The dividend of RVTY has a limited annual growth rate of 0.31%.
RVTY has been paying a dividend for at least 10 years, so it has a reliable track record.
RVTY has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)0.31%
Div Incr Years0
Div Non Decr Years23
RVTY Yearly Dividends per shareRVTY Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

RVTY pays out 11.95% of its income as dividend. This is a sustainable payout ratio.
The dividend of RVTY is growing, but earnings are growing more, so the dividend growth is sustainable.
DP11.95%
EPS Next 2Y7.31%
EPS Next 3Y9.13%
RVTY Yearly Income VS Free CF VS DividendRVTY Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
RVTY Dividend Payout.RVTY Dividend Payout, showing the Payout Ratio.RVTY Dividend Payout.PayoutRetained Earnings

REVVITY INC

NYSE:RVTY (5/20/2025, 8:04:01 PM)

After market: 93.58 0 (0%)

93.58

-0.72 (-0.76%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)04-28 2025-04-28/bmo
Earnings (Next)07-28 2025-07-28/bmo
Inst Owners93.8%
Inst Owner ChangeN/A
Ins Owners0.26%
Ins Owner Change13.32%
Market Cap11.24B
Analysts77.78
Price Target128.17 (36.96%)
Short Float %4.26%
Short Ratio3.96
Dividend
Industry RankSector Rank
Dividend Yield 0.31%
Yearly Dividend0.28
Dividend Growth(5Y)0.31%
DP11.95%
Div Incr Years0
Div Non Decr Years23
Ex-Date07-18 2025-07-18 (0.07)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.92%
Min EPS beat(2)1.58%
Max EPS beat(2)4.25%
EPS beat(4)4
Avg EPS beat(4)5.98%
Min EPS beat(4)1.58%
Max EPS beat(4)11.44%
EPS beat(8)7
Avg EPS beat(8)3.66%
EPS beat(12)10
Avg EPS beat(12)3.25%
EPS beat(16)14
Avg EPS beat(16)7.03%
Revenue beat(2)0
Avg Revenue beat(2)-1.6%
Min Revenue beat(2)-1.76%
Max Revenue beat(2)-1.43%
Revenue beat(4)0
Avg Revenue beat(4)-1.57%
Min Revenue beat(4)-1.76%
Max Revenue beat(4)-1.33%
Revenue beat(8)1
Avg Revenue beat(8)-1.79%
Revenue beat(12)2
Avg Revenue beat(12)-2.99%
Revenue beat(16)5
Avg Revenue beat(16)-2.19%
PT rev (1m)-11.12%
PT rev (3m)-8.3%
EPS NQ rev (1m)-6.87%
EPS NQ rev (3m)-7.18%
EPS NY rev (1m)-0.26%
EPS NY rev (3m)-0.33%
Revenue NQ rev (1m)0.24%
Revenue NQ rev (3m)0.06%
Revenue NY rev (1m)0.69%
Revenue NY rev (3m)0.41%
Valuation
Industry RankSector Rank
PE 18.98
Fwd PE 16.59
P/S 4.06
P/FCF 21.45
P/OCF 18.47
P/B 1.47
P/tB N/A
EV/EBITDA 16.31
EPS(TTM)4.93
EY5.27%
EPS(NY)5.64
Fwd EY6.03%
FCF(TTM)4.36
FCFY4.66%
OCF(TTM)5.07
OCFY5.42%
SpS23.05
BVpS63.56
TBVpS-12.03
PEG (NY)7.3
PEG (5Y)5.23
Profitability
Industry RankSector Rank
ROA 2.32%
ROE 3.75%
ROCE 3.43%
ROIC 2.71%
ROICexc 3%
ROICexgc 21.26%
OM 14.5%
PM (TTM) 10.35%
GM 56.25%
FCFM 18.92%
ROA(3y)3.77%
ROA(5y)5.35%
ROE(3y)6.68%
ROE(5y)10.55%
ROIC(3y)3.45%
ROIC(5y)6.13%
ROICexc(3y)3.75%
ROICexc(5y)6.55%
ROICexgc(3y)27.62%
ROICexgc(5y)43.67%
ROCE(3y)4.37%
ROCE(5y)7.76%
ROICexcg growth 3Y-28.81%
ROICexcg growth 5Y-3.08%
ROICexc growth 3Y-26.85%
ROICexc growth 5Y-10.99%
OM growth 3Y-24.12%
OM growth 5Y2.06%
PM growth 3Y-26.42%
PM growth 5Y4.45%
GM growth 3Y-4.25%
GM growth 5Y2.89%
F-Score8
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.41
Debt/FCF 6.05
Debt/EBITDA 3.87
Cap/Depr 20.31%
Cap/Sales 3.06%
Interest Coverage 250
Cash Conversion 74.35%
Profit Quality 182.86%
Current Ratio 3.58
Quick Ratio 2.99
Altman-Z 2.6
F-Score8
WACC9.64%
ROIC/WACC0.28
Cap/Depr(3y)19.72%
Cap/Depr(5y)23.7%
Cap/Sales(3y)2.9%
Cap/Sales(5y)2.67%
Profit Quality(3y)102.05%
Profit Quality(5y)111.41%
High Growth Momentum
Growth
EPS 1Y (TTM)6.71%
EPS 3Y-24.58%
EPS 5Y3.63%
EPS Q2Q%3.06%
EPS Next Y2.6%
EPS Next 2Y7.31%
EPS Next 3Y9.13%
EPS Next 5Y13.62%
Revenue 1Y (TTM)1.62%
Revenue growth 3Y-10.38%
Revenue growth 5Y-0.91%
Sales Q2Q%2.25%
Revenue Next Year3.45%
Revenue Next 2Y4.71%
Revenue Next 3Y5.29%
Revenue Next 5Y5.39%
EBIT growth 1Y8.67%
EBIT growth 3Y-32%
EBIT growth 5Y1.13%
EBIT Next Year15.34%
EBIT Next 3Y10.04%
EBIT Next 5Y11.98%
FCF growth 1Y36.87%
FCF growth 3Y-25.52%
FCF growth 5Y13.93%
OCF growth 1Y32.35%
OCF growth 3Y-23.63%
OCF growth 5Y11.57%